Immune and molecular determinants of response to neoadjuvant chemotherapy in inflammatory breast cancer.

被引：1
|
作者：
Reddy, Sangeetha Meda
Wargo, Jennifer Ann
Reuben, Alexandre
Tetzlaff, Michael T.
Roszik, Asori
Reuben, James M.
Woodward, Wendy A.
Ueno, Naoto T.
Krishnamurthy, Savitri
Mittendorf, Elizabeth Ann
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11501
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Relationship between immune checkpoint proteins and neoadjuvant chemotherapy response in breast cancer
    Kilicaslan, Umut Kina
    Aru, Basak
    Aksu, Sibel Aydin
    Aker, Fugen Vardar
    Demirel, Gulderen Yanikkaya
    Gurleyik, Meryem Gunay
    SURGICAL ONCOLOGY-OXFORD, 2024, 52
  • [32] Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
    Hamy, Anne-Sophie
    Derosa, Lisa
    Valdelievre, Constance
    Yonekura, Satoru
    Opolon, Paule
    Priour, Mael
    Guerin, Julien
    Pierga, Jean-Yves
    Asselain, Bernard
    De Croze, Diane
    Pinheiro, Alice
    Lae, Marick
    Talagrand, Laure-Sophie
    Laas, Enora
    Darrigues, Lauren
    Grandal, Beatriz
    Marangoni, Elisabetta
    Montaudon, Elodie
    Kroemer, Guido
    Zitvogel, Laurence
    Reyal, Fabien
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [34] In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival
    Ladoire, S.
    Coudert, B.
    Fumoleau, P.
    Arnould, L.
    Ghiringhelli, F.
    CANCER RESEARCH, 2010, 70
  • [35] Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Truffi, Marta
    Sottotetti, Federico
    Gafni, Nadav
    Albasini, Sara
    Piccotti, Francesca
    Morasso, Carlo
    Tibollo, Valentina
    Mocchi, Michela
    Zanella, Valentina
    Corsi, Fabio
    CANCERS, 2022, 14 (21)
  • [36] The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary breast cancer.
    Beresford, MJ
    Ah-See, M
    Daley, F
    Richman, P
    Harris, A
    Makris, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S59 - S59
  • [37] Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer.
    Kneubil, Maximiliano Cassilha
    Goulart, Karen Olivia Bazzo
    Brollo, Janaina
    Coelho, Guilherme Portela
    Mandelli, Jovana
    Orlandin, Bruna Caroline
    Corso, Leandro Luis
    Roesch-Ely, Mariana
    Henriques, Joao Antonio Pegas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [39] Correlation of pathologic and radiologic complete response in the axilla after neoadjuvant chemotherapy for breast cancer.
    Gooch, Jessica Charlotte
    Borjas, Timothy
    Kim, Jennifer Chun
    Yakes, Alexis
    Jubas, Talia
    Axelrod, Deborah M.
    Guth, Amber
    Hiotis, Karen
    Shapiro, Richard L.
    Moy, Linda
    Schnabel, Freya Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Racial differences and trends in pathologic complete response following neoadjuvant chemotherapy for breast cancer.
    Ma, Sung Jun
    Yu, Brian
    Serra, Lucas M.
    Bartl, Austin
    Farrugia, Mark
    Iovoli, Austin
    Oladeru, Oluwadamilola Temilade
    Miccio, Joseph
    Aljabab, Saif
    Fung-Kee-Fung, Simon
    Haas-Kogan, Daphne A.
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345